Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001604457-26-000003

CEO gave up 9,952 shares (to pay taxes)

  • CEO acquired 29,150 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Walker Neal · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Exercise or conversion : show line 1 in the form +29,150 1,508,974 D
2026-01-02 Shares withheld for taxes : show line 2 in the form −9,952 $2.88 $28,662 1,499,022 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-02 Exercise or conversion : show line 3 in the form Restricted Stock Units −29,150 30,034 D
Loading xslF345X05/form4-01052026_090114.xml…